Orchid ORC Q1 2026 Beat Revenue NA EPS Exceeds by Significant Garden Pet CENT Crushes Q1 2026 Estimates EPS 129 Tops Views Antalpha ANTA Q1 2026 Beat Revenue NA EPS Exceeds by Significant BioLineRx BLRX Q3 2024 Earnings Preview What to Expect Jack Ryan Ghost War Spinoff Faces Critical Headwinds on Rotten Tomatoes Paylocity PCTY Delivers Q1 2026 Beat EPS 289 vs 264 Expected HS2 Timeline Stretches to 2039 A Full Line Could Still Materialize Despite Delays